Goldman Sachs Alternatives is set to acquire a majority stake in Celnor, a testing and compliance platform backed by Inflexion. The deal values the company at €1 billion. Celnor, founded by Simon Parrington, completed 19 acquisitions in its first year under Inflexion. Parrington and his team will remain invested alongside Goldman Sachs, while Inflexion retains a minority share. The transaction is expected to close in Q1 2027, pending regulatory approval. Goldman Sachs aims to support Celnor’s global expansion, particularly in the US and Europe, and enhance its technology and operational capabilities.
Inflexion launched Celnor in 2023 with three acquisitions, followed by 16 more within 12 months. The company expanded from the UK to the US, France, and Ireland, creating 125 new jobs. Inflexion’s Tom Pemberton praised the founder-led growth in a fragmented market. Celnor’s strategy focuses on scaling its international platform through people, technology, and acquisitions. Goldman Sachs’ Jose Barreto highlighted the strong relationship built since Celnor’s formation. The partnership marks a new phase in Celnor’s long-term growth strategy.
Source: PE Insights · Summarized by HeadlinesBriefing